In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.
The round values the startup at $8.6 billion. Robotaxis using its tech go into service in London this year, and Nissan will use it for hands-free driving in personal vehicles.
This Middle School Dropout Built His AI Startup In China. Now He’s Scaling It In Silicon Valley.
This week’s Current Climate newsletter also looks at a former top Tesla engineer’s plans to rewire the grid and the outlook for solving spiking electric power prices
Común allows immigrants to open a free checking account online with a foreign ID and to send money to relatives back home at a reasonable cost.
FBI data show a rise in government impersonation fraud. From deepfake video calls to IRS impersonation schemes, AI is reshaping how criminals target everyday taxpayers.
Fusion power moves closer to commercialization. Storing data for 10,000 years. Why AI won’t necessarily take your job. All that and more in this week’s edition of The Prototype.
Even as AI took center stage in 2025, many fintechs–especially those with a business-to-business focus–thrived.
In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in clinics and more.